CD133 expression and cancer stem cells predict prognosis in high-grade oligodendroglial tumors.
about
Higher percentage of CD133+ cells is associated with poor prognosis in colon carcinoma patients with stage IIIBCancer stem cells--the current status of an old concept: literature review and clinical approachesTargeting glioma stem cells: a novel framework for brain tumorsDetection of CD133 expression in U87 glioblastoma cells using a novel anti-CD133 monoclonal antibodyNovel anti-apoptotic microRNAs 582-5p and 363 promote human glioblastoma stem cell survival via direct inhibition of caspase 3, caspase 9, and Bim.A novel fixative for immunofluorescence staining of CD133-positive glioblastoma stem cells.Expansion of CD133(+) colon cancer cultures retaining stem cell properties to enable cancer stem cell target discoveryCD133: a potential indicator for differentiation and prognosis of human cholangiocarcinoma.Clinical value of CD133 and nestin in patients with glioma: a population-based study.Overexpression of CD133 promotes drug resistance in C6 glioma cells.CD133/Src axis mediates tumor initiating property and epithelial-mesenchymal transition of head and neck cancerMusashi1 regulates breast tumor cell proliferation and is a prognostic indicator of poor survival.Allergy and inflammatory transcriptome is predominantly negatively correlated with CD133 expression in glioblastomaTherapy targets in glioblastoma and cancer stem cells: lessons from haematopoietic neoplasms.Stemness of the CT-2A Immunocompetent Mouse Brain Tumor Model: Characterization In VitroDoxorubicin-enriched, ALDH(br) mouse breast cancer stem cells are treatable to oncolytic herpes simplex virus type 1A novel, diffusely infiltrative xenograft model of human anaplastic oligodendroglioma with mutations in FUBP1, CIC, and IDH1.Prognostic value of glioma cancer stem cell isolation in survival of primary glioblastoma patients.Neurosphere formation is an independent predictor of clinical outcome in malignant glioma.CAMTA1 is a novel tumour suppressor regulated by miR-9/9* in glioblastoma stem cellsInconsistent immunohistochemical expression patterns of four different CD133 antibody clones in glioblastomaMalignant clinical features of anaplastic gliomas without IDH mutation.CD105 (Endoglin) exerts prognostic effects via its role in the microvascular niche of paediatric high grade glioma.MGMT promoter methylation status and MGMT and CD133 immunohistochemical expression as prognostic markers in glioblastoma patients treated with temozolomide plus radiotherapy.Targeting tumor metastases: Drug delivery mechanisms and technologies.Prognostic significance of stem cell marker CD133 determined by promoter methylation but not by immunohistochemical expression in malignant gliomas.Cancer stem cells and their role in metastasisOncolytic herpes simplex virus counteracts the hypoxia-induced modulation of glioblastoma stem-like cells.Nestin and CD133: valuable stem cell-specific markers for determining clinical outcome of glioma patients.Origins and clinical implications of the brain tumor stem cell hypothesis.Oligodendrocyte/type-2 astrocyte progenitor cells and glial-restricted precursor cells generate different tumor phenotypes in response to the identical oncogenes.Carbon nanotubes in hyperthermia therapy.Polycomb group protein gene silencing, non-coding RNA, stem cells, and cancer.The perivascular niche microenvironment in brain tumor progression.Brain tumor stem cells: the cancer stem cell hypothesis writ large.Cancer stem cells: a new framework for the design of tumor therapies.Thyroid cancer stem cells.Immunotherapy targeting glioma stem cells--insights and perspectives.CD133 as a biomarker for putative cancer stem cells in solid tumours: limitations, problems and challenges.What is the clinical value of cancer stem cell markers in gliomas?
P2860
Q24645020-AF6CCDD4-484A-4138-A78C-21281F9D4A9AQ27025165-F78EF7F3-E484-4F78-AD1E-E89D52F869C8Q27026818-D1B67177-9084-40DE-BF43-58D90896C3BEQ30388310-F8246BEE-79C8-4318-B19D-8CCB33B9D8CBQ30413140-C7129F7F-194C-4AF5-A479-2BFABDE6086BQ30426915-B3AA77DE-B560-401B-BD1E-2C4284F8EC24Q33794878-467D5A78-8E6D-4EDE-9E2C-DC01D462C5E1Q33974370-AEFED957-FE9E-472E-9350-6240AFCB2986Q34028947-334C0A12-0452-4F51-A491-5E9B8013A66FQ34073309-DB4720F8-B8FB-471E-B22A-A2B5F26DCDFAQ34091227-6585D86E-88D2-4887-8B6D-D4932CCD069FQ34128316-AC78EF9D-5EB0-4B0D-AE91-897620E987E4Q34132833-9FDC784E-B319-406D-B597-8A9BC8846AA7Q34154786-037E1C60-AFBA-417B-BF31-6A6717DD3CB3Q34269290-FECA70A3-3A3C-4075-921F-6F8D12C008A8Q34486691-28021F2A-F622-4CDB-95D0-75BEE1CA22AAQ34635517-AE03CD39-9FF0-44A6-8D52-CE46AC435F07Q34785641-5A2E5812-DBA3-464B-8244-62FD68A2B787Q35224959-C15834E1-4C7D-46FF-B23E-D5F3F8DB515BQ35422357-803310D1-D5B0-46A2-A609-7BBFD403C126Q35440815-766CEA7F-88A7-413A-A945-5659C09E2052Q35788726-4CB4313C-8392-4E3C-B743-0EE79D746915Q36041205-CA115E68-4E8D-411F-BE8B-5B420EC2C6E0Q36552798-3453D72E-7E01-440B-AF47-9BD344113D4BQ36557855-E57A0075-EA01-4755-BF47-436260426017Q36661089-8C9C6EB2-90B2-4C28-8D3B-73F04BC92CFFQ36698757-6C42B136-E091-4F06-8078-4DCAC6FE5A97Q36861550-29EB0490-79EF-449D-ABA1-A99AC48312A2Q37077666-A0CD0581-A5D6-405B-AE8F-103F80AA7C02Q37230949-D3DAA0CB-B268-4C59-821F-A74783AB980DQ37231529-BA954B0D-91FF-4E82-9EA3-B5F7469C19DCQ37557801-593D3248-20DD-4527-AA89-30560B74820DQ37629613-80D14E27-070C-4A2D-A2CF-3FCA91CF38DCQ37780433-D991F145-00D8-46A1-8E4E-F2E3A0E31674Q37783774-6F3BC73C-FDC8-4FA3-9A56-B2332506ACA4Q37796629-3C8FC317-342D-4C2E-AD56-35F92D475A94Q37905534-68C27261-3ED3-40B1-9254-83880713F6FAQ37971408-A5BEEB5F-05CE-4692-A640-42FBB7ADBE95Q38035206-E21564BD-DD60-4AC7-904D-A2CE7F5F9932Q38081776-006B6247-99D5-44BA-8B5D-D4FF8C8693C8
P2860
CD133 expression and cancer stem cells predict prognosis in high-grade oligodendroglial tumors.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年学术文章
@wuu
2008年学术文章
@zh-cn
2008年学术文章
@zh-hans
2008年学术文章
@zh-my
2008年学术文章
@zh-sg
2008年學術文章
@yue
2008年學術文章
@zh
2008年學術文章
@zh-hant
name
CD133 expression and cancer st ...... grade oligodendroglial tumors.
@en
CD133 expression and cancer st ...... grade oligodendroglial tumors.
@nl
type
label
CD133 expression and cancer st ...... grade oligodendroglial tumors.
@en
CD133 expression and cancer st ...... grade oligodendroglial tumors.
@nl
prefLabel
CD133 expression and cancer st ...... grade oligodendroglial tumors.
@en
CD133 expression and cancer st ...... grade oligodendroglial tumors.
@nl
P2093
P2860
P1433
P1476
CD133 expression and cancer st ...... grade oligodendroglial tumors.
@en
P2093
Alexander Brawanski
Christoph P Beier
Dagmar Beier
Martin Proescholdt
Ulrich Bogdahn
Wolfgang Dietmaier
P2860
P304
P356
10.1111/J.1750-3639.2008.00130.X
P577
2008-03-26T00:00:00Z